Sara Leschner
Impact in
- Biotechnology top 0.5%
- Cancer Research and Treatments
- Immunology top 5%
- Immune cells in cancer
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
Papers in
-
- Cancer Research and Treatments 15
- Genetics 11
- Virus-based gene therapy research 10
- Co-authors
- Siegfried WeißJadwiga JabłońskaKathrin WestphalStefan LienenklausHolger LoessnerLisa AndzinskiChunfu WuSiegfried Weiss
- Journals
- International Journal of Cancer (2 papers)Oncotarget (2 papers)PLoS ONE (2 papers)Cancer Research (2 papers)Microbes and Infection (1 paper)
- Partner nations
- GermanySwitzerland
In The Last Decade
Sara Leschner
18 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 82
- Biotechnology 670
- Immunology 553
- Oncology 382
- Genetics 376
- Biomedical Engineering 523
Countries citing papers authored by Sara Leschner
This map shows the geographic impact of Sara Leschner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Leschner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Leschner more than expected).
Fields of papers citing papers by Sara Leschner
This network shows the impact of papers produced by Sara Leschner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Leschner. The network helps show where Sara Leschner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sara Leschner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 10 | |
| 2 | 2017 | 32 | |
| 3 | 2016 | 3 | |
| 4 | 2016 | 9 | |
| 5 | 2016 | 31 | |
| 6 | 2015 | 71 | |
| 7 | 2014 | 66 | |
| 8 | 2014 | 19 | |
| 9 | 2013 | 147 | |
| 10 | 2012 | 7 | |
| 11 | 2011 | 40 | |
| 12 | 2010 | 82 | |
| 13 | 2010 | 476 | |
| 14 | 2009 | 43 | |
| 15 | 2009 | 183 | |
| 16 | 2008 | 156 | |
| 17 | 2007 | 87 | |
| 18 | 2007 | 29 |
About Sara Leschner
Sara Leschner is a scholar working on Biotechnology, Genetics, Biomedical Engineering, Endocrinology and Immunology and Allergy, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Research and Treatments (15 papers), Virus-based gene therapy research (10 papers), Nanoplatforms for cancer theranostics (9 papers), Bacteriophages and microbial interactions (3 papers), bioluminescence and chemiluminescence research (3 papers), Immune cells in cancer (2 papers), Chemokine receptors and signaling (2 papers) and Salmonella and Campylobacter epidemiology (1 paper). The work is most often cited by research in Biotechnology (670 citations), Immunology (553 citations), Oncology (382 citations), Genetics (376 citations) and Biomedical Engineering (523 citations). Sara Leschner has collaborated with scholars based in Germany and Switzerland. Frequent co-authors include Siegfried Weiß, Jadwiga Jabłońska, Kathrin Westphal, Stefan Lienenklaus, Holger Loessner, Lisa Andzinski, Chunfu Wu, Siegfried Weiss, Dino Kocijancic and Marcin Łyszkiewicz. Their work appears in journals such as International Journal of Cancer, Oncotarget, PLoS ONE, Cancer Research and Microbes and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.